Recruiting Hemophilia Studies in Philadelphia
About Hemophilia Clinical Trials in Philadelphia
Hemophilia is a rare genetic bleeding disorder in which blood does not clot properly due to deficiency of clotting factors. Hemophilia A (factor VIII) and hemophilia B (factor IX) are the most common types. Treatment includes factor replacement therapy and newer approaches like gene therapy.
There are currently 2 hemophilia clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 418 participants. Research is being sponsored by Pfizer. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hemophilia Clinical Trials in Philadelphia — FAQ
Are there hemophilia clinical trials in Philadelphia?
Yes, there are 2 hemophilia clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What hemophilia treatments are being tested?
The 2 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for hemophilia.
Data updated July 19, 2026 from ClinicalTrials.gov